Abstract
A dystrophin-containing glycoprotein complex (DGC) links the basal lamina surrounding each muscle fibre to the fibre’s cytoskeleton, providing both structural support and a scaffold for signalling molecules. Mutations in genes encoding several DGC components disrupt the complex and lead to muscular dystrophy. Here we show that mice deficient in α-dystrobrevin, a cytoplasmic protein of the DGC, exhibit skeletal and cardiac myopathies. Analysis of double and triple mutants indicates that α-dystrobrevin acts largely through the DGC. Structural components of the DGC are retained in the absence of α-dystrobrevin, but a DGC-associated signalling protein, nitric oxide synthase, is displaced from the membrane and nitric-oxide-mediated signalling is impaired. These results indicate that both signalling and structural functions of the DGC are required for muscle stability, and implicate α-dystrobrevin in the former.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Tinsley, J. M., Blake, D. J., Zuellig, R. A. & Davies, K. E. Increasing complexity of the dystrophin-associated protein complex. Proc. Natl Acad. Sci. USA 91, 8307– 8313 (1994).
Straub, V. & Campbell, K. P. Muscular dystrophies and the dystrophin-glycoprotein complex. Curr. Opin. Neurol. 10, 168–175 (1997).
Sadoulet-Puccio, H. M. & Kunkel, L. M. Dystrophin and its isoforms. Brain Pathol. 6 25– 35 (1996).
Lim, L. E. & Campbell, K. P. The sarcoglycan complex in limb-girdle muscular dystrophy. Curr. Opin. Neurol. 11, 443–452 (1998).
Ozawa, E., Noguchi, S., Mizuno, Y., Hagiwara, Y. & Yoshida, M. From dystrophinopathy to sarcoglycanopathy: evolution of a concept of muscular dystrophy. Muscle Nerve 21 , 421–438 (1998).
Cox, G. F. & Kunkel, L. M. Dystrophies and heart disease . Curr. Opin. Cardiol. 12, 329– 343 (1997).
Engel, A. G., Yamamoto, M. & Fischbeck, K. H. in Myology (eds Engel, A. G. & Franzini-Armstrong, C.) 1133–1187 (McGraw-Hill, New York, 1994).
Jung, D., Yang, B. & Meyer, J. Identification and characterization of the dystrophin anchoring site on β-dystroglycan . J. Biol. Chem. 270, 27305– 27310 (1995).
Rybakova, I. N., Amann, K. J. & Ervasti, J. M. A new model for the interaction of dystrophin with F-actin. J. Cell Biol. 135, 661– 672 (1996).
Henry, M. D. & Campbell, K. P. Dystroglycan: an extracellular matrix receptor linked to the cytoskeleton. Curr. Opin. Cell Biol. 8, 625–631 ( 1996).
Pall, E. A., Bolton, K. M. & Ervasti, J. M. Differential heparin inhibition of skeletal muscle α-dystroglycan binding to laminins. J. Biol. Chem. 271, 3817–3821 (1996).
Anderson, J. T., Rogers, R. P. & Jarrett, H. W. Ca2+ calmodulin binds to the carboxyl-terminal domain of dystrophin. J. Biol. Chem. 271, 6605–6610 (1996).
Iwata, Y., Pan, Y., Yoshida, T., Hanada, H. & Shigekawa, M. a-1-Syntrophin has distinct binding sites for actin and calmodulin. FEBS Lett. 423, 173– 177 (1998).
Yang, B. et al. SH3 domain-mediated interaction of dystroglycan and Grb2. J. Biol. Chem. 270, 11711–11714 (1995).
Ahn, A. H. et al. The three human syntrophin genes are expressed in diverse tissues, have distinct chromosomal locations, and each bind to dystrophin and its relatives. J. Biol. Chem. 271, 2724 –2730 (1996).
Peters, M. F., Adams, M. E. & Froehner, S. C. Differential association of syntrophin pairs with the dystrophin complex. J. Cell Biol. 138, 81–93 (1997).
Carr, C., Fischbach, G. D. & Cohen, J. B. A novel 87,000-Mr protein associated with acetylcholine receptors in Torpedo electric organ and vertebrate skeletal muscle. J. Cell Biol. 109, 1753–1764 (1989).
Wagner, K. R., Cohen, J. B. & Huganir, R. L. The 87K postsynaptic membrane protein from Torpedo is a protein-tyrosine kinase substrate homologous to dystrophin. Neuron 10, 511–522 ( 1993).
Yoshida, M. et al. Dystrophin-associated protein A0 is a homologue of the Torpedo 87K protein. FEBS Lett. 367, 311– 314 (1995).
Sadoulet-Puccio, H. M., Khurana, T. S., Cohen, J. B. & Kunkel, L. M. Cloning and characterization of the human homologue of a dystrophin related phosphoprotein found at the Torpedo electric organ post-synaptic membrane . Hum. Mol. Genet. 5, 489– 496 (1996).
Peters, M. F. et al. β-Dystrobrevin, a new member of the dystrophin family. Identification, cloning, and protein associations. J. Biol. Chem. 272, 31561–31569 ( 1997).
Blake, D. J., Nawrotzki, R., Loh, N. Y., Gorecki, D. C. & Davies, K. E. β-Dystrobrevin, a member of the dystrophin-related protein family. Proc. Natl Acad. Sci. USA 95, 241–246 ( 1998).
Puca, A. A. et al. Identification and characterization of a novel member of the dystrobrevin gene family. FEBS Lett. 425, 7–13 (1998).
Brenman, J. E. et al. Interaction of nitric oxide synthase with the postsynaptic density protein PSD-95 and α1-syntrophin mediated by PDZ domains. Cell 84, 757–767 ( 1996).
Gee, S. H. et al. Interaction of muscle and brain sodium channels with multiple members of the syntrophin family of dystrophin-associated proteins. J. Neurosci. 18, 128–137 (1998).
Schultz, J. et al. Specific interactions between the syntrophin PDZ domain and the voltage-gated sodium channels. Nature Struct. Biol. 5, 19–24 (1998).
Balasubramanian, S., Fung, E. T. & Huganir, R. L. Characterization of the tyrosine phosphorylation and distribution of dystrobrevin isoforms. FEBS Lett. 432, 133–140 (1998).
Sadoulet-Puccio, H. M., Rajala, M. & Kunkel, L. M. Dystrobrevin and dystrophin: an interaction through coiled-coil motifs. Proc. Natl Acad. Sci. USA 94, 12413–12418 (1997).
Peters, M. F. et al. Differential membrane localization and intermolecular associations of α-dystrobrevin isoforms in skeletal muscle. J. Cell Biol. 142, 1269–1278 ( 1998).
Thomas, G. D. et al. Impaired metabolic modulation of alpha-adrenergic vasoconstriction in dystrophin-deficient skeletal muscle. Proc. Natl Acad. Sci. USA 95, 15090–15095 ( 1998).
Bredt, D. S. NO skeletal muscle derived relaxing factor in Duchenne muscular dystrophy . Proc. Natl Acad. Sci. USA 95, 14592– 14593 (1998).
Lau, K. S. et al. Skeletal muscle contractions stimulate cGMP formation and attenuate vascular smooth muscle myosin phosphorylation via nitric oxide. FEBS Lett. 431, 71–74 ( 1998).
Blake, D. J., Nawrotzki, R., Peters, M. F., Froehner, S. C. & Davies, K. E. Isoform diversity of dystrobrevin, the murine 87-kDa postsynaptic protein. J. Biol. Chem. 271, 7802–7810 (1996).
DiMario, J. X., Uzman, A. & Strohman, R. C. Fiber regeneration is not persistent in dystrophic (mdx) mouse skeletal muscle. Dev. Biol. 148, 314–321 (1991).
Torres, L. F. & Duchen, L. W. The mutant mdx: inherited myopathy in the mouse. Morphological studies of nerves, muscles and end-plates . Brain 110, 269–299 (1987).
Grady, R. M. et al. Skeletal and cardiac myopathies in mice lacking utrophin and dystrophin: a model for Duchenne muscular dystrophy. Cell 90, 729–738 (1997).
Deconinck, A. E. et al. Utrophin-dystrophin-deficient mice as a model for Duchenne muscular dystrophy. Cell 90, 717– 727 (1997).
Matsuda, R., Nishikawa, A. & Tanaka, H. Visualization of dystrophic muscle fibers in mdx mouse by vital staining with Evans blue: evidence of apoptosis in dystrophin-deficient muscle. J. Biochem. 118, 959– 964 (1995).
Straub, V., Rafael, J. A., Chamberlain, J. S. & Campbell, K. P. Animal models for muscular dystrophy show different patterns of sarcolemmal disruption. J. Cell Biol. 139, 375– 385 (1997).
Brenman, J. E., Chao, D. S., Xia, H., Aldape, K. & Bredt, D. S. Nitric oxide synthase complexed with dystrophin and absent from skeletal muscle sarcolemma in Duchenne muscular dystrophy. Cell 82, 743–752 ( 1995).
Chang, W. J. et al. Neuronal nitric oxide synthase and dystrophin-deficient muscular dystrophy. Proc. Natl Acad. Sci. USA 93, 9142–9147 (1996).
Thomas, G. D. & Victor, R. G. Nitric oxide mediates contraction-induced attenuation of sympathetic vasoconstriction in rat skeletal muscle. J. Physiol. (Lond.) 506, 817–826 (1998).
Huang, P. L., Dawson, T. M., Bredt, D. S., Snyder, S.H. & Fishman, M.C. Targeted disruption of the neuronal nitric oxide synthase gene. Cell 75, 1273 –1280 (1993).
Metzinger, L. et al. Dystrobrevin deficiency at the sarcolemma of patients with muscular dystrophy. Hum. Mol. Genet. 6, 1185–1191 (1997).
Crosbie, R. H. et al. Mdx muscle pathology is independent of nNOS perturbation . Hum. Mol. Genet. 7, 823– 829 (1998).
Chao, D. S., Silvagno, F. & Bredt, D. S. Muscular dystrophy in mdx mice despite lack of neuronal nitric oxide synthase. J. Neurochem. 71 , 784 (1998).
Kameya, S. et al. α1-Syntrophin gene disruption results in the absence of neuronal-type nitric-oxide synthase at the sarcolemma but does not induce muscle degeneration. J. Biol. Chem. 274, 2193–2200 (1999).
Ambrose, H. J., Blake, D. J., Nawrotski, R. A. & Davies, K. E. Genomic organization of the mouse dystrobrevin gene: comparative analysis with the dystrophin gene. Genomics 39, 359 (1997)
Grady, R. M., Merlie, J. P. & Sanes, J. R. Subtle neuromuscular defects in utrophin-deficient mice. J. Cell Biol. 136, 871 ( 1997)
Acknowledgements
We thank S. Froehner and M. Peters for antibodies. This work was supported by the NIH and MDA (J.R.S. and R.M.G.).
Correspondence and requests for materials should be addressed to R.M.G.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Grady, R., Grange, R., Lau, K. et al. Role for α-dystrobrevin in the pathogenesis of dystrophin-dependent muscular dystrophies. Nat Cell Biol 1, 215–220 (1999). https://doi.org/10.1038/12034
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/12034
This article is cited by
-
Variants in DTNA cause a mild, dominantly inherited muscular dystrophy
Acta Neuropathologica (2023)
-
The α-dystrobrevins play a key role in maintaining the structure and function of the extracellular matrix–significance for protein elimination failure arteriopathies
Acta Neuropathologica Communications (2021)
-
Dystrophin R16/17-syntrophin PDZ fusion protein restores sarcolemmal nNOSμ
Skeletal Muscle (2018)
-
Humanizing the mdx mouse model of DMD: the long and the short of it
npj Regenerative Medicine (2018)
-
Molecular Therapies for Muscular Dystrophies
Current Treatment Options in Neurology (2018)